09:12 AM EDT, 06/21/2024 (MT Newswires) -- Health care stocks were steady premarket Friday with the Health Care Select Sector SPDR Fund ( XLV ) up 0.1% and the iShares Biotechnology ETF ( IBB ) inactive recently.

Sarepta Therapeutics ( SRPT ) rallied past 33% after saying the US Food and Drug Administration approved the expansion of Elevidys to include patients ages 4 and above with Duchenne muscular dystrophy and a confirmed mutation in the DMD gene.

Ocugen ( OCGN ) was up almost 2% after saying the Data and Safety Monitoring Board approved proceeding with the high dose of its experimental drug OCU410ST to treat Stargardt disease, a rare eye disease, in the dose-escalation phase of the study.

Mustang Bio ( MBIO ) was down nearly 10% after saying it expects to raise $2.5 million from a registered direct offering of 6.13 million shares at $0.41 each.